首页> 美国卫生研究院文献>Journal of Clinical and Translational Hepatology >A Review on the Management of Biliary Complications after Orthotopic Liver Transplantation
【2h】

A Review on the Management of Biliary Complications after Orthotopic Liver Transplantation

机译:原位肝移植术后胆道并发症的处理研究进展

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

Orthotopic liver transplantation is the definitive treatment for end-stage liver disease and hepatocellular carcinomas. Biliary complications are the most common complications seen after transplantation, with an incidence of 10–25%. These complications are seen both in deceased donor liver transplant and living donor liver transplant. Endoscopic treatment of biliary complications with endoscopic retrograde cholangiopancreatography (commonly known as ERCP) has become a mainstay in the management post-transplantation. The success rate has reached 80% in an experienced endoscopist’s hands. If unsuccessful with ERCP, percutaneous transhepatic cholangiography can be an alternative therapy. Early recognition and treatment has been shown to improve morbidity and mortality in post-liver transplant patients. The focus of this review will be a learned discussion on the types, diagnosis, and treatment of biliary complications post-orthotopic liver transplantation.
机译:原位肝移植是终末期肝病和肝细胞癌的明确治疗方法。胆道并发症是移植后最常见的并发症,发生率为10–25%。在已故的供体肝移植和活体供体肝移植中均可见到这些并发症。内镜逆行胰胆管造影术(通常称为ERCP)内镜治疗胆道并发症已成为移植后管理的主要手段。在经验丰富的内窥镜专家的手中,成功率已达到80%。如果未能成功使用ERCP,则可以采用经皮肝穿刺胆道造影术作为替代疗法。早期识别和治疗已显示可改善肝移植术后患者的发病率和死亡率。这篇综述的重点将是关于原位肝移植后胆道并发症的类型,诊断和治疗的学术讨论。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号